120 related articles for article (PubMed ID: 19117755)
1. Electrochemical activity of holotransferrin and its electrocatalysis-mediated process of artemisinin.
Cai HH; Cai J; Yang PH
Bioorg Med Chem Lett; 2009 Feb; 19(3):863-6. PubMed ID: 19117755
[TBL] [Abstract][Full Text] [Related]
2. Transferrin's mechanism of interaction with receptor 1.
Hémadi M; Kahn PH; Miquel G; El Hage Chahine JM
Biochemistry; 2004 Feb; 43(6):1736-45. PubMed ID: 14769051
[TBL] [Abstract][Full Text] [Related]
3. Effects of artemisinin-tagged holotransferrin on cancer cells.
Lai H; Sasaki T; Singh NP; Messay A
Life Sci; 2005 Jan; 76(11):1267-79. PubMed ID: 15642597
[TBL] [Abstract][Full Text] [Related]
4. Holotransferrin enhances selective anticancer activity of artemisinin against human hepatocellular carcinoma cells.
Deng XR; Liu ZX; Liu F; Pan L; Yu HP; Jiang JP; Zhang JJ; Liu L; Yu J
J Huazhong Univ Sci Technolog Med Sci; 2013 Dec; 33(6):862-865. PubMed ID: 24337849
[TBL] [Abstract][Full Text] [Related]
5. Dynamic structure of human serum transferrin from transient electric birefringence experiments.
van Haeringen B; de Lange F; van Stokkum IH; Srai SK; Evans RW; van Grondelle R; Bloemendal M
Proteins; 1995 Oct; 23(2):233-40. PubMed ID: 8592704
[TBL] [Abstract][Full Text] [Related]
6. Reduction of circulating redox-active iron by apotransferrin protects against renal ischemia-reperfusion injury.
de Vries B; Walter SJ; von Bonsdorff L; Wolfs TG; van Heurn LW; Parkkinen J; Buurman WA
Transplantation; 2004 Mar; 77(5):669-75. PubMed ID: 15021827
[TBL] [Abstract][Full Text] [Related]
7. The role of transferrin in actinide(IV) uptake: comparison with iron(III).
Jeanson A; Ferrand M; Funke H; Hennig C; Moisy P; Solari PL; Vidaud C; Den Auwer C
Chemistry; 2010 Jan; 16(4):1378-87. PubMed ID: 19950335
[TBL] [Abstract][Full Text] [Related]
8. Development of a dihydroartemisinin-resistant Molt-4 leukemia cell line.
Park J; Lai HC; Singh M; Sasaki T; Singh NP
Anticancer Res; 2014 Jun; 34(6):2807-10. PubMed ID: 24922643
[TBL] [Abstract][Full Text] [Related]
9. Self-assembled films of hemoglobin/laponite/chitosan: application for the direct electrochemistry and catalysis to hydrogen peroxide.
Shan D; Han E; Xue H; Cosnier S
Biomacromolecules; 2007 Oct; 8(10):3041-6. PubMed ID: 17824641
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of formation of the complex between transferrin and bismuth, and interaction with transferrin receptor 1.
Miquel G; Nekaa T; Kahn PH; Hémadi M; El Hage Chahine JM
Biochemistry; 2004 Nov; 43(46):14722-31. PubMed ID: 15544343
[TBL] [Abstract][Full Text] [Related]
11. Binding and release of iron by gel-encapsulated human transferrin: evidence for a conformational search.
Navati MS; Samuni U; Aisen P; Friedman JM
Proc Natl Acad Sci U S A; 2003 Apr; 100(7):3832-7. PubMed ID: 12486226
[TBL] [Abstract][Full Text] [Related]
12. Stimulatory effect of ascorbate on iron transfer from bleomycin to apotransferrin.
Løvstad RA
Biometals; 1998 Sep; 11(3):199-202. PubMed ID: 9850562
[TBL] [Abstract][Full Text] [Related]
13. Enhanced delivery of artemisinin and its analogues to cancer cells by their adducts with human serum transferrin.
Yang Y; Zhang X; Wang X; Zhao X; Ren T; Wang F; Yu B
Int J Pharm; 2014 Jun; 467(1-2):113-22. PubMed ID: 24661944
[TBL] [Abstract][Full Text] [Related]
14. Electrochemical detection of triacetone triperoxide employing the electrocatalytic reaction of iron(II/III)-ethylenediaminetetraacetate and hydrogen peroxide.
Laine DF; Roske CW; Cheng IF
Anal Chim Acta; 2008 Feb; 608(1):56-60. PubMed ID: 18206994
[TBL] [Abstract][Full Text] [Related]
15. The mechanism of iron release from the transferrin-receptor 1 adduct.
Hémadi M; Ha-Duong NT; El Hage Chahine JM
J Mol Biol; 2006 May; 358(4):1125-36. PubMed ID: 16564538
[TBL] [Abstract][Full Text] [Related]
16. Myoglobin/sol-gel film modified electrode: direct electrochemistry and electrochemical catalysis.
Wang Q; Lu G; Yang B
Langmuir; 2004 Feb; 20(4):1342-7. PubMed ID: 15803717
[TBL] [Abstract][Full Text] [Related]
17. Heme mediates cytotoxicity from artemisinin and serves as a general anti-proliferation target.
Zhang S; Gerhard GS
PLoS One; 2009 Oct; 4(10):e7472. PubMed ID: 19862332
[TBL] [Abstract][Full Text] [Related]
18. Cobalt and the iron acquisition pathway: competition towards interaction with receptor 1.
Chikh Z; Hémadi M; Miquel G; Ha-Duong NT; El Hage Chahine JM
J Mol Biol; 2008 Jul; 380(5):900-16. PubMed ID: 18579154
[TBL] [Abstract][Full Text] [Related]
19. Structural consequences of binding of UO2(2+) to apotransferrin: can this protein account for entry of uranium into human cells?
Vidaud C; Gourion-Arsiquaud S; Rollin-Genetet F; Torne-Celer C; Plantevin S; Pible O; Berthomieu C; Quéméneur E
Biochemistry; 2007 Feb; 46(8):2215-26. PubMed ID: 17266333
[TBL] [Abstract][Full Text] [Related]
20. Anticancer properties of artemisinin derivatives and their targeted delivery by transferrin conjugation.
Nakase I; Lai H; Singh NP; Sasaki T
Int J Pharm; 2008 Apr; 354(1-2):28-33. PubMed ID: 17942255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
